GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Easy Bio Inc (XKRX:353810) » Definitions » Debt-to-Revenue

Easy Bio (XKRX:353810) Debt-to-Revenue : 0.54 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Easy Bio Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Easy Bio's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩51,204 Mil. Easy Bio's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩77,698 Mil. Easy Bio's annualized Revenue for the quarter that ended in Mar. 2024 was ₩237,610 Mil. Easy Bio's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.54.


Easy Bio Debt-to-Revenue Historical Data

The historical data trend for Easy Bio's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easy Bio Debt-to-Revenue Chart

Easy Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
0.42 0.40 0.53 0.50

Easy Bio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.48 0.56 0.48 0.54

Competitive Comparison of Easy Bio's Debt-to-Revenue

For the Biotechnology subindustry, Easy Bio's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Easy Bio's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Easy Bio's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Easy Bio's Debt-to-Revenue falls into.



Easy Bio Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Easy Bio's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(51824.327 + 30453.615) / 165385.091
=0.50

Easy Bio's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(51204.155 + 77697.525) / 237610.396
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Easy Bio Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Easy Bio's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Easy Bio (XKRX:353810) Business Description

Traded in Other Exchanges
N/A
Address
310, Gangnam-daero, 4th Floor, Gangnam-gu, Seoul, KOR, 06253
Easy Bio Inc is a bio-technology company. The company conducts research, manufactures and markets animal feed products in South Korea.

Easy Bio (XKRX:353810) Headlines

No Headlines